Skip to content

Comparison of Open and Laparoscopic Distal Gastrectomy for T4a Gastric Cancer

Comparison of Laparoscopic Versus Open Distal Gastrectomy for T4a Gastric Cancer: a Prospective Randomized Control Trial

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04384757
Enrollment
240
Registered
2020-05-12
Start date
2020-07-29
Completion date
2028-06-30
Last updated
2025-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Keywords

gastric cancer, laparoscopic gastrectomy, T4a stage

Brief summary

There are more than 75% of patients with gastric cancer who are diagnosed in advanced stage in Vietnam, most of cases in T4a. The purpose of this study is to compare the technical feasibility, early and long term outcomes of open and laparoscopic distal gastrectomy for gastric adenocarcinoma in T4A stage

Detailed description

Gastric cancer poses a significant public health problem. It is one of the most common cancers in Vietnam . Despite recent advances in multimodality treatment and targeted therapy, surgery remains the first option of treament for this disease. For resectable gastric cancer, complete removal of macroscopic and microscopic lesions and/or combined resections and also regional or extended lymphadenectomy should represent in the world now. Since laparoscopic gastrectomy for early gastric cancer (EGC) was firstly reported in 1994 , this technique has become standard for treatment of EGC due to the many advantages of mininally invasive surgery and also in oncologic outcomes. Laparoscopic gastrectomy for advanced gastric cancer AGC was first applied by Uyama in 2000, and then, many surgeons have used it for treatment of AGC, especially in Japan, Korea and China. However, the real role of laparoscop for treament of (AGC) is still controversial in term of technical feasibility, safety and oncologic aspect. Paragastric inflammatory strands may occur in T4a tumor so that laparoscopic technique is difficult to radically perform. Peritoneal seeding of malignant cells, intra- and postoperative complications, trocarts metastasis may risk during procedures. Despite, some studies have demonstrated the safety and the short-term benefits of LG for T4a gastric cancer, the number of these studies and sample sizes have been still inadequate to give good evidence for applying it. and long-term oncologic outcomes There are more than 75% of patients with gastric cancer who are diagnosed in advanced stage in Vietnam, most of cases in T4a. The purpose of this study is to compare the technical feasibility, early and long term outcomes of open and laparoscopic distal gastrectomy for gastric adenocarcinoma in T4A stage.

Interventions

Distal gastrectomy and standard D2 lymphadenectomy

Sponsors

University Medical Center Ho Chi Minh City (UMC)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Pathologic finding by gastric endoscopy: confirmed gastric adenocarcinoma * Age: 18 - 80 year old * Tumor located at the middle or lower third of the stomach * Preoperative cancer stage (CT scan stage): cT4aN0M0, cT4aN1M0, cT4aN2M0, cT4aN3M0 * ASA score: ≤ 3 * Informed consent patients (explanation about our clinical trials is provided to the patients or patrons, if patient is not available)

Exclusion criteria

* Concurrent cancer or patient who was treated due to other cancer before the patient was diagnosed gastric cancer * Had another treatment methods, such as chemotherapy, immunotherapy, or radiotherapy * Pregnant patient * Combined resection * Total gastrectomy

Design outcomes

Primary

MeasureTime frameDescription
3 year overall survival by Kaplan Mayer3 year after surgeryThe percentage of people in this study who are alive three years after surgery.
3 year relapse-free survival by Kaplan Mayer3 year after surgeryThe percentage of people in this study who are alive without recurrence three years after surgery.

Secondary

MeasureTime frameDescription
operative morbidity30 days after surgeryThe rate of postoperative bleeding and the rate of postoperative leakage
operative mortality30 days after surgeryThe rate of postoperative dead
hospital stay30 days after surgeryThe number of days between surgery and discharge
operative timeintraoperativeThe duration of a surgical procedure in minutes.
Resected lymph nodesintraoperativethe number of lymph nodes harvested after surgery

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026